GSK573719/GW642444(VI)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK573719/GW642444(VI), covering 2017-07-25 to 2017-07-25. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment [Phase 1]